openPR Logo
Press release

Explore the Global Macrogol/Polyethylene Glycol (PEG) Market Projected To Reach Higher Growth Rate By 2026| BASF, Sigma Aldrich, DOW Chemical Company etc.

03-13-2020 09:38 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Reports And Data

Macrogol, Polyethylene Glycol (PEG) Market

Macrogol, Polyethylene Glycol (PEG) Market

Market Size - USD 3212.1 million in 2018, Market Growth - CAGR of 5.3%, Market Trends - Increasing use in Cancer therapy.

According to the current analysis of Reports and Data, the global macrogol/polyethylene glycol (PEG) market was valued at USD 3,212.1 million in 2018 and is expected to reach USD 4,934.6 million by year 2026, at a CAGR of 5.3%. Macrogol have been shown to provide water solubility and biocompatibility in medicines and different applications, and the ability to attach a range of reactive functional groups to the terminal positions of these polymers has greatly increased their utility. For instance, Macrogol 400 is very hydrophilic, which renders it a useful ingredient in drug formulations to augment the solubility and bioavailability of weakly water-soluble drugs.

Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/1707

Key participants include - BASF, Sigma Aldrich, DOW Chemical Company, Lotte Chemical, Ineos, Croda, Liaoning Oxiranchem, Jiangsu Haian Petrochemical Plant, Shanghai Bronkow Chemical, and Oxiteno.

For the purpose of this report, Reports and Data has segmented the global macrogol/polyethylene glycol market on the basis of type, technology type, end use, and region:

Type (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
PEG 200
PEG 400
PEG 3350
PEG 4000
PEG 6000
PEG 8000
Others

Administration Route (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
Oral
Nasogastric
Ophthalmic
Topical

Usage (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
Excipient
API

End Use (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
Pharmaceutical Uses
Veterinary Health
Biotechnology
Biomedical
Other end uses

Regional Outlook (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)
North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Any Query or Discount? Ask our Expert @ https://www.reportsanddata.com/discount-enquiry-form/1707

The pharmaceutical industry is the emerging segment in this industry due to the fact of growing the manufacturing of eye drops and laxatives coupled with the increase of the pharmaceutical industry has improved the use of macrogol as a solvent which will force to increase the market growth in future. Besides, rising demand for water-based coatings and paints for utility in automobile and development industries has additionally elevated the demand for macrogol/polyethylene glycol. This will additionally have an on affect the market positively.

However, the presence of alternatives, for mono ethylene glycol (MEG) and a range of different glycol ethers, will pose a credible risk to the polyethylene glycol industry and negatively affect its future. The stringent environmental protocols associated to the manufacturing of private care and medical products may additionally obstruct the market boom for polyethylene glycol.

Further key findings from the report suggest

Chronic constipation is a common disorder, affecting between 2-35% of the population, according to a recent report from European Review for Medical and Pharmacological Sciences. It is characterized by dry feces and infrequent excretions from the body. Macrogol improves stool frequency and consistency, thus making it a suitable drug to treat chronic constipation.

The PEG-3350 segment is projected to increase at a CAGR of 5.8% during the forecast period. This grade is used for short-term relief of constipation as well as for long-term use in constipation of various causes, including in multiple sclerosis and Parkinson's disease patients (an oftenoverlooked non-motor symptom) as well as constipation caused by pharmaceutical drugs such as opioids and anticholinergics.

Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/macrogol-polyethylene-glycol-peg-market

Major selling points of this research report

Gives the reader a holistic comprehension of the global market
Identifies the recent trends and estimated growth rate for the forecast duration
Helps industry experts, investors, and other participants implement lucrative expansion approaches
Provides accurate market insights to take informed decisions through presentations and other tools
Outlines the competitive landscapes with the individual market share of top vendors

Contact Us:
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Explore the Global Macrogol/Polyethylene Glycol (PEG) Market Projected To Reach Higher Growth Rate By 2026| BASF, Sigma Aldrich, DOW Chemical Company etc. here

News-ID: 1965949 • Views:

More Releases from Reports And Data

U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billion by 2034, Transforming National Transportation
U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billio …
The U.S. Electric Vehicle (EV) Charging Infrastructure Market reached a value of USD 5.48 billion in 2024 and is projected to surge to USD 56.73 billion by 2034, fueled by a robust CAGR of 26.1% over the period. This unprecedented growth underscores the sector's central role in decarbonizing transportation and meeting the soaring demands of electric mobility. Market Drivers Federal & State Policies: Major initiatives, including the Bipartisan Infrastructure Law and significant
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Driven by Sustainability and Cost Efficiency
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Dr …
The global Automotive Refurbished Turbochargers Market is set to grow from USD 0.9 billion in 2024 to USD 1.7 billion by 2034, recording a steady compound annual growth rate (CAGR) of 6.00%. This growth is being propelled by rising demand for affordable, fuel-efficient automotive solutions and stricter environmental regulations pushing the need for emission-reducing technologies. Get Free Sample Report and Related Graphs & Charts @https://www.reportsanddata.com/sample-enquiry-form/19490 Passenger vehicles remain the largest segment of
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Driven by EV Boom and Emission Standards
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Dr …
The global Automotive Powertrain Cooling System Market is projected to grow from USD 4.3 billion in 2024 to USD 8.2 billion by 2034, at a CAGR of 6.60%, according to the latest market study. This growth is fueled by the rising demand for fuel-efficient vehicles, increasing electric vehicle (EV) sales, and stricter global emission regulations. Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.reportsanddata.com/sample-enquiry-form/19489 Electric and
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
The global Automotive Inverter Market is on track for strong expansion, with forecasts projecting it will rise from USD 4.8 billion in 2024 to USD 16.9 billion by 2034, marking a compound annual growth rate (CAGR) of 13.2%. This rapid growth is being propelled by the increasing adoption of electric and hybrid vehicles, along with continued innovation in inverter technologies. Electric vehicles (EVs) are the main driver behind this surge, as

All 5 Releases


More Releases for PEG

Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever. PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications. "Biopharma PEG is committed to delivering high-purity multi-arm
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development. Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,